Hepatitis B vaccination is the most effective measure to prevent HBV infection and its consequences. The best strategy to eradicate HBV infection is a universal vaccination program. This study was a descriptive cross sectional study aimed at evaluating the efficiency of HBV vaccine in term of anti-HBs Ab level among vaccinated health care workers (HCWs) in Bahri Teaching Hospital, Khartoum state, Sudan. Ninety HCWs agreed to participate in this study, HBV antibody level (quantitative antibody) against HBsAg were measured using ELISA technique. The majority of study population 66 (73.33%) were aged (21-30 years), the active age groups (21-30) and (31-40) revealed remarkable reduction of HBsAb titer, 29 (43.93%) and 11 (55%), respectively. A total of 49 (54.4%) participants showed antibody titers above 10 IU/mL, 14 (15.6%) of them revealed strong response with anti-HBs Ab titers >100 IU/mL while HBsAb titers less than 10 IU/mL was detected in 41(45.6%) participants. A total of 83(92.22%) of the study population had the vaccine dose at proper interval whereas 7(7.78%) had the vaccine at irregular time. Eighteen18 (27.3%) of the participants who had the vaccine less than 5 years ago and 22 (91.7) of candidates who received the vaccine more than 5years ago did not respond to vaccine. Sixty-six (66; 73.33%) of the entire participants were females and 24 (26.67%) were males, out of which 28(42.2%) and 13(54.2%) of male and female, respectively fail to develop anti-HBsAb titer 10 IU/mL.
Conclusion: this study revealed that other non immunological factors influence the outcome of vaccination; interval after vaccination and chronic disease were found to be significantly correlated (P<0.05) with antibody titers following hepatitis B vaccination.
This study contributes in the existing literature regarding the importance of checking the post vaccination status of HCWs as it ensure safety of employee, reduces rate of transmission and functioning as a cost effective exercise at individual as well as national level.
T. F. Baumert, R. Thimme, and F. Weizsäcker, "Pathogenesis of hepatitis B virus infection," World J. Gastroenterol, vol. 7:13, pp. 82-90, 2007.
D. E. Fry, "Occupational blood-borne diseases in surgery," Am. J. Surg., vol. 190, pp. 249-254, 2005.
V. L. S. Resende, M. H. G. Abreu, S. M. Paiva, R. Teixeira, and L. A. Pordeus, "Concerns regarding hepatitis B vaccination and post-vaccination test among Brazilian dentists," Virol. J., vol. 13, p. 154, 2010.
J. H. Kao and D. Chen, Overview of hepatitis B and C virus. Infectious cause of cancer: Target for intervention. Totowa NJ: Humana Press, 2000.
A. Prüss-Ustün, E. Rapiti, and Y. Hutin, "Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers," Am. J. Ind. Med., vol. 48, pp. 482-490, 2005.
R. Fed, "Occupational exposure to bloodborne pathogens-OSHA," Final Rule, vol. 56, pp. 64004–182, 1991.
M. Abe, S. Abkar, and M. Onji, "Zinc and hepatitis B virus immunization," Hepatol. Res., vol. 35, pp. 1-2, 2006.
H. Xiao-wen, S. Shu-han, H. Zhen-lin, L. Jun, J. Lei, Z. Feng-juan, Z. Ya-nan, and G. Ying-jun, "Augmented humoral and cellular immune responses of a hepatitis B DNA vaccine encoding HbsAg by protein boosting," Vaccine, vol. 23, pp. 1649-1656, 2005.
A. J. Roome, S. J. Walsh, M. L. Cartter, and J. L. Hadler, "Hepatitis B vaccine responsiveness in connecticut public safety personnel," J. A. M .A., vol. 270, pp. 2931-2934, 1993.
M. Krajden, G. McNabb, and M. Petric, "The laboratory diagnosis of hepatitis B virus," Can. J. Infect. Dis. Med. Microbiol., vol. 16, pp. 65–72, 2005.
M. J. Alter, "Epidemiology and prevention of hepatitis B," Semin Liver Dis., vol. 23, pp. 39-46, 2003.
A. H. Elduma and N. S. Saeed, "Hepatitis B virus infection among staff in three hospitals in Khartoum, Sudan," E. M. H. J., vol. 17, pp. 474-478, 2011.
R. C. Wood, K. L. MacDonald, K. E. White, C. W. Hedbertn, M. Harrison, and M. T. Osterholm, "Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers," J. A. M. A., vol. 270, pp. 2935–2939, 1993.
M. M. Hussein and M. M. Hussein, "Immune response to hepatitis B vaccine in health-care workers," The Egyptian Journal of Hospital Medicine, vol. 2012, pp. 596– 603, 2012.
M. Saberifiroozi, S. Gholamzadeh, and A. Serati, "The long term immunityamong health care workers vaccinated against hepatitis B virus in a large referral hospital in Southern Iran," Arch. Iran Med., vol. 3, pp. 204 – 207, 2006.
M. Zeeshan, K. Jabeen, N. A. Ali, A. W. Ali, S. Z. Farooqui, V. Mehraj, and A. Zafa, "Evaluation of immune response to hepatitis B vaccine in health care workers at a tertiary care hospital in Pakistan: An observational prospective study," BMC Infect. Dis., vol. 2007, p. 120, 2007.
A. Kane, J. Lloyd, M. Zaffran, L. Simonsen, and M. Kane, "Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: Model-based regional estimates," Bull World Health Organ., vol. 77, pp. 801–807, 1999.
E. B. Hollinger, C. N. Kim, and H. U. Lee, "Factor influencing the immune response to hepatitis B vaccine, booster dose guideline and vaccine protocol recommendation," Am. J. Med., vol. 4;87, pp. 36S-40S, 1989.
R. A. Tohme, D. Awosika-Olumo, C. Nielsen, S. Khuwaja, J. Scott, J. Xing, J. Drobeniuc, D. Hu, C. Turner, T. Wafeeg, U. Sharapov, and P. Spradling, "Evaluation of hepatitis B vaccine immunogenicity among older adults during an outbreak response in assisted living facilities," Vaccine, vol. 29, pp. 9316-9320, 2011.
E. Platkov, E. Shlyakhov, Y. Glick, S. Khalemsky, and A. Fischbein, "Immunologic evaluation of hepatitis B vaccine application in hospital staff," Int. J Occup. Med. Environ. Health, vol. 16, pp. 249-253, 2003.
S. M. Hosseini, R. Ranjbar, A. Hassan, and T. Mohammed, "Evaluation of the level of HBV antibody titer after HBV vaccination among children in Tehran, Iran," Hepat. Mon., vol. 9, pp. 150-153, 2009.